IFITM2 and pancreatic ductal adenocarcinoma: Notably, another study identified IFITM2 as a receptor for a secreted form of the chaperone BAG3, showing that IFITM2 mediated signaling through PI3K and p38 MAPK pathways (119) to promote tumorigenesis in a model of pancreatic ductal adenocarcinoma.